Oncomine database revealed that NDUFS1 mRNA expression was increased significantly in colorectal cancer, leukemia, lymphoma, melanoma and prostate cancer while was decreased significantly in sarcoma (Figure 1C). Here, NDUFS1 is linked to prostate carcinoma.